Julie Dumonceaux

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Amyotrophic Lateral Sclerosis

Top Venues

International journal of molecular sciences

Journal of personalized medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Laurane Mackels, Virginie Mariot, Laura Buscemi, Laurent Servais, Julie Dumonceaux
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. International journal of molecular sciences 25 (16) (2024)
Laurane Mackels, Virginie Mariot, Laura Buscemi, Laurent Servais, Julie Dumonceaux
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. International journal of molecular sciences 25 (16) (2024)
Ekene Anakor, Vanessa Milla, Owen Connolly, Cécile Martinat, Pierre Francois Pradat, Julie Dumonceaux, William John Duddy, Stephanie Duguez
The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes. Cells 11 (5) (2022)
Ekene Anakor, Laura Le Gall, Julie Dumonceaux, William John Duddy, Stephanie Duguez
Exosomes in Ageing and Motor Neurone Disease: Biogenesis, Uptake Mechanisms, Modifications in Disease and Uses in the Development of Biomarkers and Therapeutics. Cells 10 (11) (2021)
Virginie Mariot, Romains Joubert, Laura Le Gall, Eva Sidlauskaite, Christophe Hourde, William John Duddy, Thomas Voit, Maximilien Bencze, Julie Dumonceaux
RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy. Journal of cachexia, sarcopenia and muscle (2021)
Romains Joubert, Virginie Mariot, Julie Dumonceaux
One-hour universal protocol for mouse genotyping. Muscle & nerve 61 (6) (2020)
Laura Le Gall, Eva Sidlauskaite, Virginie Mariot, Julie Dumonceaux
Therapeutic Strategies Targeting DUX4 in FSHD. Journal of clinical medicine 9 (9) (2020)
Romains Joubert, Virginie Mariot, Marine Charpentier, Jean Paul Concordet, Julie Dumonceaux
Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD? Journal of personalized medicine 11 (1) (2020)